Protagonist Therapeutics, Inc
PTGXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Protagonist Therapeutics, Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 12 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 25, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| ALLIANCEBERNSTEIN L.P. | 2026-03-31 | 73,790 | $6.44M | SEC filing |
| NEXTBio Capital Management LP | 2026-03-31 | 229,619 | $24.2M | SEC filing |
| BROWN BROTHERS HARRIMAN & CO | 2026-03-31 | 81 | $8.54K | SEC filing |
| DecisionPoint Financial, LLC | 2026-03-31 | 4 | $422 | SEC filing |
| EXCHANGE TRADED CONCEPTS, LLC | 2026-03-31 | 23,773 | $2.51M | SEC filing |
| Creative Planning | 2026-03-31 | 47,971 | $5.06M | SEC filing |
| WPG Advisers, LLC | 2026-03-31 | 97 | $10.2K | SEC filing |
| AE Wealth Management LLC | 2026-03-31 | 2,888 | $304K | SEC filing |
| Moody Aldrich Partners LLC | 2026-03-31 | 53,893 | $5.68M | SEC filing |
| Vise Technologies, Inc. | 2026-03-31 | 2,996 | $262K | SEC filing |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 2026-03-31 | 127,818 | $13.5M | SEC filing |
| Eagle Health Investments LP | 2026-03-31 | 179,322 | $18.9M | SEC filing |
| Velan Capital Investment Management LP | 2026-03-31 | 3,700 | $390K | SEC filing |
| CANADA LIFE ASSURANCE Co | 2026-03-31 | 47,440 | Not shown | SEC filing |
| RAYMOND JAMES FINANCIAL INC | 2026-03-31 | 177,361 | $17.8M | SEC filing |
| NATIXIS ADVISORS, LLC | 2026-03-31 | 22,638 | Not shown | SEC filing |
| Duquesne Family Office LLC | 2026-03-31 | 159,700 | Not shown | SEC filing |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | 2026-03-31 | 26,528 | Not shown | SEC filing |
| STATE OF WISCONSIN INVESTMENT BOARD | 2026-03-31 | 30,767 | $3.24M | SEC filing |
| INTECH INVESTMENT MANAGEMENT LLC | 2026-03-31 | 13,006 | $1.37M | SEC filing |
- Each value is checked against Protagonist Therapeutics, Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 4 rows: the filed value is about 1,000 times too small for the share count at Protagonist Therapeutics, Inc's share price.
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-23 | Waddill William D. · Director | Common Stock | S — Open market or private sale | −9,000 | 117.94 | SEC filing |
| 2026-06-10 | Waddill William D. · Director | Common Stock | S — Open market or private sale | −9,000 | 107.68 | SEC filing |
| 2026-05-29 | Waddill William D. · Director | Common Stock | S — Open market or private sale | −9,000 | 99.64 | SEC filing |
| 2026-05-12 (amended) | PATEL DINESH V PH D · President and CEO | Common Stock | S — Open market or private sale | −75,000 | 100.12 | SEC filing |
| 2026-05-08 | Giraudo Bryan · Director | Common Stock | S — Open market or private sale | −5,130 | 100.00 | SEC filing |
| 2026-05-08 | Giraudo Bryan · Director | Common Stock | S — Open market or private sale | −6,000 | 100.00 | SEC filing |
| 2026-05-07 | Giraudo Bryan · Director | Common Stock | S — Open market or private sale | −12,000 | 100.07 | SEC filing |
| 2026-05-07 | Giraudo Bryan · Director | Common Stock | S — Open market or private sale | −36,000 | 100.14 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-23 | Waddill William D. · Director | Common Stock | M — Exercise or conversion of derivative security | +9,000 | SEC filing |
| 2026-06-23 | Waddill William D. · Director | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −9,000 | SEC filing |
| 2026-06-10 | Waddill William D. · Director | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −3,000 | SEC filing |
| 2026-06-10 | Waddill William D. · Director | Common Stock | M — Exercise or conversion of derivative security | +3,000 | SEC filing |
| 2026-06-10 | Waddill William D. · Director | Common Stock | M — Exercise or conversion of derivative security | +6,000 | SEC filing |
| 2026-06-10 | Waddill William D. · Director | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −6,000 | SEC filing |
| 2026-05-29 | Waddill William D. · Director | Common Stock | M — Exercise or conversion of derivative security | +9,000 | SEC filing |
| 2026-05-29 | Waddill William D. · Director | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −9,000 | SEC filing |
Showing 8 of 40 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.